Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Melanoma‐specific survival before and after inclusion in a familial melanoma dermatologic surveillance program in CDKN2A mutation carriers and non‐carriers

Journal of the European Academy of Dermatology and Venereology(2023)10.1111/jdv.18589Source: DataRank Database

Melanoma‐specific survival before and after inclusion in a familial melanoma dermatologic surveillance program in CDKN2A mutation carriers and non‐carriers is a research paper published in Journal of the European Academy of Dermatology and Venereology (2023). On theSindex it has a DataRank of 0.655. It has been cited 11 times, with 9 citing works in its 1-hop citation network.

N/A

0.655DataRank · unranked

Scored on demand from live citation data

11 citations · 9 citing works in its network

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (5 grants)Impact (FWCI 0.74)OA: hybridTopics (34)IDs (PubMed, PMC, OpenAlex)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (0/2)

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

DataRank Breakdown

Base Score 57%Citation Network 43%

Base Score Contribution

0.373

From this paper's citation signal

Citation Network Contribution

0.282

From 5 citing papers with measurable signal

Learn more about DataRank methodology →

Top 5 citers driving the network score

Ranked by each citer's contribution to N(p) — log1p(C_q) divided by its reference count — out of 9 citers.

Surveillance, CDKN2A and survival of familial melanoma
Journal of the European Academy of Dermatology and Venereology202310 citations9 referencesContributes 0.266
Psychological Distress and Quality of Life in Families With a Germline CDKN2A Pathogenic Variant
Molecular Genetics & Genomic Medicine20252 citations48 referencesContributes 0.023
Assessment of RAS-RAF-MAPK Pathway Mutation Status in Healthy Skin, Benign Nevi, and Cutaneous Melanomas: Pilot Study Using Droplet Digital PCR
International Journal of Molecular Sciences20248 citations103 referencesContributes 0.021
Evaluation and enhancement of the prognostic ability of the eighth edition of TNM staging in cutaneous malignant melanoma: a population-based study, using machine learning, of 111 871 patients
British Journal of Dermatology20261 citations38 referencesContributes 0.018
Small-molecule drug discovery in malignant melanoma: current status and prospective developments
Medicinal Chemistry Research20251 citations266 referencesContributes 0.003

Authors (4)

Jan Lapins ORCID,Christina Sköldmark,Hildur Helgadóttir ORCID,Maria Pissa

Live enrichment

PubMed:36156317 PMC:PMC10091727 OpenAlex:https://openalex.org/W4297264654

Cancerfonden

Grant: 21 1486 Pj

Cancerfonden

Grant: 20 0156 F

Radiumhemmets Forskningsfonder

Grant: 194092

Stockholms Läns Landsting

Grant: 20200638

Swedish Cancer Society

Grant: unidentified

unidentified

FWCI

0.74

Citation Percentile

0.7%

Citation Trend

2022

2023

2024

2025

2026

hybridLicense: cc-by-nc

journalhttps://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/jdv.18589

publisherhttps://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/jdv.18589

publisherhttps://onlinelibrary.wiley.com/doi/pdf/10.1111/jdv.18589

publisherhttps://onlinelibrary.wiley.com/doi/full-xml/10.1111/jdv.18589

journalhttps://doi.org/10.1111/jdv.18589

Fields of Study

Cutaneous Melanoma Detection and ManagementMelanoma and MAPK PathwaysNonmelanoma Skin Cancer Studies03 medical and health sciences0302 clinical medicine

MeSH Terms

Melanoma, Cutaneous MalignantCutaneous Malignant MelanomaAdultHumansMelanomaMutationSkin NeoplasmsGerm-Line MutationCyclin-Dependent Kinase Inhibitor p16Genetic Predisposition to Disease

Keywords

CDKN2AMedicineMelanomaProportional hazards modelCancerOncologySurvival analysisCancer registryInternal medicineCancer researchAdultSkin NeoplasmsCutaneous Malignant MelanomaOriginal Articles and Short ReportsMutationHumansGenetic Predisposition to DiseaseCyclin-Dependent Kinase Inhibitor p16Germ-Line Mutation

Sustainable Development Goals

SDG 3: 3. Good healthSDG 0: Good health and well-being